Works matching IS 09147187 AND DT 2018 AND VI 32 AND IP 4

Results: 8

Comparison of choline influx from dynamic 18F-Choline PET/CT and clinicopathological parameters in prostate cancer initial assessment.

Published in:

2018

By:

Palard-Novello, Xavier;
Blin, Anne-Lise;
Bourhis, David;
Garin, Etienne;
Salaün, Pierre-Yves;
Devillers, Anne;
Querellou, Solène;
Bourguet, Patrick;
Le Jeune, Florence;
Saint-Jalmes, Hervé

Publication type:

journal article

Prognostic implications of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/CT in patients with glioma.

Published in:

2018

By:

Toriihara, Akira;
Ohtake, Makoto;
Tateishi, Kensuke;
Hino-Shishikura, Ayako;
Yoneyama, Tomohiro;
Kitazume, Yoshio;
Inoue, Tomio;
Kawahara, Nobutaka;
Tateishi, Ukihide

Publication type:

journal article

18F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18F-FPYBF-2 PET imaging.

Published in:

2018

By:

Nishii, Ryuichi;
Higashi, Tatsuya;
Kagawa, Shinya;
Okuyama, Chio;
Kishibe, Yoshihiko;
Takahashi, Masaaki;
Okina, Tomoko;
Suzuki, Norio;
Hasegawa, Hiroshi;
Nagahama, Yasuhiro;
Ishizu, Koichi;
Oishi, Naoya;
Kimura, Hiroyuki;
Watanabe, Hiroyuki;
Ono, Masahiro;
Saji, Hideo;
Yamauchi, Hiroshi

Publication type:

journal article

Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay.

Published in:

2018

By:

Tsujikawa, Tetsuya;
Narita, Norihiko;
Kanno, Masafumi;
Takabayashi, Tetsuji;
Fujieda, Shigeharu;
Okazawa, Hidehiko

Publication type:

journal article

68Ga-DOTATATE PET-CT imaging in carotid body paragangliomas.

Published in:

2018

By:

Şimşek, Duygu Has;
Şanlı, Yasemin;
Kuyumcu, Serkan;
Başaran, Bora;
Mudun, Ayşe

Publication type:

journal article

Improvement in the measurement error of the specific binding ratio in dopamine transporter SPECT imaging due to exclusion of the cerebrospinal fluid fraction using the threshold of voxel RI count.

Published in:

2018

By:

Mizumura, Sunao;
Nishikawa, Kazuhiro;
Murata, Akihiro;
Yoshimura, Kosei;
Ishii, Nobutomo;
Kokubo, Tadashi;
Morooka, Miyako;
Kajiyama, Akiko;
Terahara, Atsuro

Publication type:

journal article

Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism.

Published in:

2018

By:

Ozderya, Aysenur;
Temizkan, Sule;
Gul, Aylin Ege;
Ozugur, Sule;
Cetin, Kenan;
Aydin, Kadriye

Publication type:

journal article

The feasibility of 18F-FES and 18F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERα in ERα+ breast cancer.

Published in:

2018

By:

Liu, Shuai;
Gu, Bingxin;
Zhang, Jianping;
Zhang, Yongping;
Xu, Xiaoping;
Yuan, Huiyu;
Zhang, Yingjian;
Yang, Zhongyi

Publication type:

journal article

Works matching IS 09147187 AND DT 2018 AND VI 32 AND IP 4

Comparison of choline influx from dynamic <sup>18</sup>F-Choline PET/CT and clinicopathological parameters in prostate cancer initial assessment.

Prognostic implications of <sup>62</sup>Cu-diacetyl-bis (N<sup>4</sup>-methylthiosemicarbazone) PET/CT in patients with glioma.

<sup>18</sup>F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man <sup>18</sup>F-FPYBF-2 PET imaging.

Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay.

<sup>68</sup>Ga-DOTATATE PET-CT imaging in carotid body paragangliomas.

Improvement in the measurement error of the specific binding ratio in dopamine transporter SPECT imaging due to exclusion of the cerebrospinal fluid fraction using the threshold of voxel RI count.

Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism.

The feasibility of <sup>18</sup>F-FES and <sup>18</sup>F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERα in ERα+ breast cancer.